References
- Adams MA, Anderson MA, Myles JD, Khalatbari S, Scheiman JM (2012). Self-expanding metal stents (SEMS) provide superior outcomes compared to plastic stents for pancreatic cancer patients undergoing neoadjuvant therapy. J Gastrointest Oncol, 3, 309-13.
- Chen WQ, Liang D, Zhang SW, Zheng RS, He YT (2013). Pancreatic cancer incidence and mortality patterns in China, 2009. Asian Pac J Cancer Prev, 14, 7321-4. https://doi.org/10.7314/APJCP.2013.14.12.7321
- Choudhary A, Bechtold ML, Arif M, et al (2011). Pancreatic stents for prophylaxis against post-ERCP pancreatitis: a meta-analysis and systematic review. Gastrointest Endosc, 73, 275-82. https://doi.org/10.1016/j.gie.2010.10.039
- Decker C, Christein JD, Phadnis MA, Wilcox CM, Varadarajulu S (2011). Biliary metal stents are superior to plastic stents for preoperative biliary decompression in pancreatic cancer. Surg Endosc, 25, 2364-7. https://doi.org/10.1007/s00464-010-1552-6
- Huggett MT, Pereira SP (2011). Diagnosing and managing pancreatic cancer. Practitioner, 255, 21-5.
- Kruse EJ (2010). Palliation in pancreatic cancer. Surg Clin North Am, 90, 355-64. https://doi.org/10.1016/j.suc.2009.12.004
- Lee TH, Moon JH, Choi HJ, et al (2012). Prophylactic temporary 3F pancreatic duct stent to prevent post-ERCP pancreatitis in patients with a difficult biliary cannulation: a multicenter, prospective, randomized study. Gastrointest Endosc, 76, 578-85. https://doi.org/10.1016/j.gie.2012.05.001
- Lee V, Cheng H, Li G, Saif MW (2012). Quality of life in patients with pancreatic cancer. JOP, 13, 182-4.
- Maosheng D, Ohtsuka T, Ohuchida J, et al (2001). Surgical bypass versus metallic stent for unresectable pancreatic cancer. J Hepatobiliary Pancreat Surg, 8, 367-73. https://doi.org/10.1007/s005340170010
- Mazaki T, Mado K, Masuda H, Shiono M (2014). Prophylactic pancreatic stent placement and post-ERCP pancreatitis: an updated meta-analysis. J Gastroenterol, 49, 343-55. https://doi.org/10.1007/s00535-013-0806-1
- Mazaki T, Masuda H, Takayama T (2010). Prophylactic pancreatic stent placement and post-ERCP pancreatitis: a systematic review and meta-analysis. Endoscopy, 42, 842-53. https://doi.org/10.1055/s-0030-1255781
- Saif MW (2011). Pancreatic neoplasm in 2011: an update. JOP, 12, 316-21.
- Salehimarzijarani B, Dadvar Z, Mousavi M, et al (2012). Risk factors for post-ERCP cholangitis in patients with pancreatic cancer from a single referral center in Iran. Asian Pac J Cancer Prev, 13, 1539-41. https://doi.org/10.7314/APJCP.2012.13.4.1539
- Uomo I (2011). Pain in pancreatic cancer: does drug treatment still play a role? JOP, 12, 435-7.
- Wang K, Chen Z, Meng Z, et al (2011). Analgesic effect of high intensity focused ultrasound therapy for unresectable pancreatic cancer. Int J Hyperthermia, 27, 101-7. https://doi.org/10.3109/02656736.2010.525588
- Wehrmann T, Riphaus A, Frenz MB, Martchenko K, Stergiou N (2005). Endoscopic pancreatic duct stenting for relief of pancreatic cancer pain. Eur J Gastroenterol Hepatol, 17, 1395-400. https://doi.org/10.1097/00042737-200512000-00020
- Wyse JM, Carone M, Paquin SC, Usatii M, Sahai AV (2011). Randomized, double-blind, controlled trial of early endoscopic ultrasound-guided celiac plexus neurolysis to prevent pain progression in patients with newly diagnosed, painful, inoperable pancreatic cancer. J Clin Oncol, 29, 3541-6. https://doi.org/10.1200/JCO.2010.32.2750
- Zhou W, Li Y, Zhang Q, et al (2011). Risk factors for postendoscopic retrograde cholangiopancreatography pancreatitis: a retrospective analysis of 7, 168 cases. Pancreatology, 11, 399-405. https://doi.org/10.1016/S1424-3903(11)80094-3
Cited by
- Obstructive pancreatitis secondary to a pancreatic metastasis from lung cancer treated with nasopancreatic drainage pp.1865-7265, 2019, https://doi.org/10.1007/s12328-019-00944-4